5PD - The role of EGFR inhibitor (EGFRi) in immune cell infiltration and CD8+ T-cell activation in EGFR mutant lung cancer

Autor: Li, F., Lizee, G., Hwu, P., Du, X., Deng, L., Talukder, A., Katailiha, A., Zou, Q., Roszik, J., Hawke, D., Jackson, K., Bradley, S., Wang, Y., Ataullakhanov, R., Bagaev, A., Kotlov, N., Svekolkin, V., Miheecheva, N., Frenkel, F., Sonnemann, H.
Zdroj: In Annals of Oncology October 2019 30 Supplement 5:v2-v2
Databáze: ScienceDirect